END-TO-END RESEARCH EXCELLENCE

01 Botanical Sourcing & Authentication

• Medicinal plants and botanical raw materials enter the research pipeline through controlled identification, sourcing and authentication.
• Relevant plant material is prepared as the starting point for extract and phytopharmaceutical research.

02 Phytopharma Research

• Botanical extracts are investigated to understand their phytochemical composition and potential health applications.
• Plant-derived extracts and phytoconstituents form the foundation for Gplife’s botanical research and targeted product development.

03 Phytochemical Screening

• Extracts are screened to identify relevant phytoconstituents and active chemical components.
• Promising constituents are evaluated in relation to biological pathways, biomarkers and targeted health objectives.

04 Active & Synergistic Candidate Selection

• Potentially relevant phytoconstituents are assessed individually and in combinations for their intended biological role.
• Synergistic combinations can be investigated to identify promising botanical blends for targeted applications.

05 Drug / Product Discovery

• Promising botanical candidates are evaluated against defined biological targets and health areas.
• AI-assisted research can support interpretation and prioritization of promising candidates.

06 Formulation Development

• Selected extracts and phytoconstituents are developed into suitable dosage forms such as tablets, capsules or powders.
• Formulation parameters are optimized for consistency, stability, compatibility and intended product performance.

07 Analytical Research

• Analytical methods are used to identify, quantify and monitor relevant active constituents and formulation characteristics.
• Raw materials, intermediates and finished formulations are evaluated using appropriate analytical procedures.

08 Toxicology & Safety Evaluation

• Relevant formulations and ingredients undergo appropriate safety evaluation during the development pathway.
• Preclinical studies may assess acute, repeated-dose or other applicable toxicity parameters.

09 Pharmacokinetics & Bioavailability

• Selected active constituents may be studied to understand absorption, distribution, metabolism and elimination.
• Formulation technologies can be explored where solubility, dissolution or absorption presents a development challenge.

10 Clinical Research

• Promising formulations can progress to appropriately designed human studies to evaluate safety, tolerability and relevant outcomes.
• Clinical studies may assess biomarkers, physiological parameters and predefined health outcomes.

11 Quality Assurance

• Quality systems are integrated across research, development and manufacturing activities.
• Documented procedures and controlled processes support consistency, traceability and compliance.

12 Quality Control

• Raw materials, in-process materials and finished products undergo applicable quality-control testing.
• Finished batches are evaluated against predefined requirements before release.

13 Regulatory Affairs

• Scientific, formulation, safety, analytical and manufacturing documentation is organized according to applicable regulatory requirements.
• Product information, labeling and supporting documentation are reviewed through the relevant regulatory pathway.

14 Controlled Manufacturing

• Approved formulations move from development into controlled manufacturing processes.
• Materials are weighed, blended and processed according to defined manufacturing procedures, with in-process controls.

15 Tablet Compression & Finishing

• The formulated blend is converted into the final tablet dosage form through controlled compression.
• Tablets may undergo applicable finishing processes such as coating, inspection or other dosage-form operations.

16 Final Testing & Product Release

• Completed products undergo final quality checks against applicable release requirements.
• Only batches meeting defined quality and documentation requirements proceed to release.

17 Packaging & Market-Ready Product

• Released tablets are packed using controlled packaging processes designed to maintain product integrity.
• Applicable product identification, batch information, expiry and labeling details are applied before the product enters distribution.